Mealey Publications (King of Prussia, PA), a unit of LexisNexis,
has begun the publication of "Mealey's Litigation Report:
Heart Drugs & Devices," a new monthly report that focuses on
litigation involving drugs and medical devices used to treat heart
disease. An annual subscription costs $950.
Content in the report covers a range of topics related to
litigation involving heart drugs and devices, including:
pharmaceuticals, including cholesterol-lowering drugs (statins),
anti-platlet drugs, ACE inhibitors and antiarrhythmia drugs; and, heart
devices including implantable cardio-defibrillators, automatic external
defibrillators, left ventricular assist devices, pacemakers, pacemaker
leads, human heart valves, animal heart valves, balloon catheters,
drug-coated stents and symmetry bypass connectors.
The new report includes news stories, case summaries, attorney
listings, and the full text of court documents. Subscribers also receive
commentary articles and email bulletins of breaking news.
Related Mealey publications include "Mealey's Emerging
Drugs & Devices," "Mealey's Litigation Report: Health
& Medical" and "Mealey's Managed Care Liability
Report."
COPYRIGHT 2007 JK Publishing,
Inc Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2007, Gale Group. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.